Hib-MenC vaccine

Haemophilus influenzae type b and Neisseria meningitidis serogroup C conjugate vaccine · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hib-MenC vaccine, covering 2016-10-07 to 2016-10-07. Get the full timeline:

Most recent: Clinical Trial Update: Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine [Phase 3]

See pricing